跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 25,596 条关于
“Victorian Heart Institute”
全部
25,596
临床试验
15,891
药物
1,255
机构
1,091
资讯
7,359
8个月前
PUMA Trial Challenges Standard Heart Surgery Monitoring with $3.7M Study Comparing Invasive Devices
去年
TGA Approves Wegovy for Cardiovascular Disease Prevention in Overweight Patients
去年
Zerlasiran Shows Durable Lp(a) Reduction in ALPACAR-360 Trial
去年
Obicetrapib Demonstrates Significant LDL-C Reduction in HeFH Patients in Phase III BROOKLYN Trial
去年
Muvalaplin, a Novel Oral Medication, Effectively Lowers Lipoprotein(a) Levels in Clinical Trial
去年
Obicetrapib Shows Promise in Phase 3 BROADWAY Trial, Reduces LDL-C and MACE
去年
Muvalaplin Shows Promise in Lowering Lipoprotein(a) Levels in High-Risk Patients
去年
Oral Muvalaplin Shows Promise in Lowering Lipoprotein(a) Levels in Phase 2 Trial
去年
Obicetrapib Shows Sustained LDL-C Reduction in HeFH Patients in Phase 3 Trial
2年前
Obicetrapib Shows Significant LDL-C Reduction in Phase 3 Trial for Heterozygous Familial Hypercholesterolemia
第 1 页,共 736 页
上一页
下一页